Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Reaction mass of sodium aqua[5-{[2-hydroxy-4-(hydroxy-kO)-5-{[2-(hydroxy-kO)-3,5-dinitrophenyl]diazenyl}phenyl]diazenyl}naphthalene-1-sulfonato(3-)]ferrate(1-) and sodium diaqua(chloro)[5-{[2-hydroxy-4-(hydroxy-kO)-5-{[2-(hydroxy-kO)-3,5-dinitrophenyl]diazenyl-kN2}phenyl]diazenyl}naphthalene-1-sulfonato(3-)]ferrate(1-)
EC number: 700-899-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute Oral toxicity
Rat: LD50 (m/f) > 2200 mg/kg bw (EU B.1; BASF AG, 1993)
Rat:LD50 (m/f) > 5000 mg/kg bw (OECD 401; BASF AG, 1984)
Acute Inhalation toxicity
Rat:LC50 (m/f) > 5200 mg/m3, 4h (OECD 403; BASF AG, 1988)
Acute Dermal toxicity
Actually, there is no information available.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 200 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 5 200 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The following considerations based on EC 400 -720 -9 are also applicable to EC: 700- 899 -6. For read across justification see the relevant document in the read across section
There are valid, guideline conform, in vivo data available for the assessment of the acute toxicity of the test substance.Acute Oral toxicity
The acute oral toxicity of the test substance was investigated in two groups of 3 male and 3 female rats according to EU B.1/OECD 401 guideline, given a limit dose of 2200 mg/kg bw as gavage. Clinical signs were discoloured feces for male and female rats and piloerection and smeared fur in the anogenital area in male animals. No mortality or gross pathological changes were reported.
In the second study the acute oral toxicity of the test substance was investigated according to OECD guideline 401 in two groups of 3 male and 3 female rats, given a limit dose of 5000 mg/kg bw as gavage. Clinical signs were black feces for male and female rats. No mortality or gross pathological changes were reported.
Acute Inhalation toxicity
The acute dust inhalation toxicity of the test substance was investigated according to OECD 403 guideline in 5 male and 5 female rats. The test material was applied as dust (dust generator; dose determination: gravimetrically) via head/nose inhalation at a limit dose level of 5200 mg/m3 for 4 hours. Clinical signs during exposure were attempts to escape and irregular breathing. After exposure no deaths and no signs of toxicity were noted.
Acute Dermal toxicity
Appropriate data to assess the acute dermal toxicity of the test article are not available.
Justification for classification or non-classification
The following considerations based on EC 400 -720 -9 are also applicable to EC: 700- 899 -6. For read across justification see the relevant document in the read across section
Acute Oral toxicityBased on the criteria defined by the EU and the GHS system, the test substance needs not to be labelled for acute oral toxicity because no death occurred in the highest dosing group of 5000 mg/kg bw in male and female animals that could be attributed to the test substance administration.
Acute Inhalation toxicity
For acute inhalation toxicity the test substance needs also not to be labelled according to the criteria defined by the EU and the GHS system since no death occurred at the highest dose level of 5200 mg/l.
Acute Dermal toxicity
Actually, there is no indication given for a classification according to this endpointInformation on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.